In vitro studies in HLA-A2+ breast cancer cell lines noted that the elimination of CSCs with ALDH-specific CD8+ T cells, severely limited the development of the tumor as well as metastases, while in vitro studies in xenograft-bearing immunodeficient rodents reported prolonged survival [132,133]. The gene discussed is CD8A; the disease is neoplasm.